42 related articles for article (PubMed ID: 7364922)
1. Tumoral Calcinosis.
Alam A; Sree Ram MN; Manrai K; Bhardwaj R
Med J Armed Forces India; 2007 Apr; 63(2):180-1. PubMed ID: 27407982
[No Abstract] [Full Text] [Related]
2. Congenital Hyperphosphatemic Conditions Caused by the Deficient Activity of FGF23.
Ito N; Fukumoto S
Calcif Tissue Int; 2021 Jan; 108(1):104-115. PubMed ID: 31965220
[TBL] [Abstract][Full Text] [Related]
3. Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.
Chakhtoura M; Ramnitz MS; Khoury N; Nemer G; Shabb N; Abchee A; Berberi A; Hourani M; Collins M; Ichikawa S; El Hajj Fuleihan G
Osteoporos Int; 2018 Sep; 29(9):1987-2009. PubMed ID: 29923062
[TBL] [Abstract][Full Text] [Related]
4. Dialysis as a Treatment Option for a Patient With Normal Kidney Function and Familial Tumoral Calcinosis Due to a Compound Heterozygous FGF23 Mutation.
Goldenstein PT; Neves PD; Balbo BE; Elias RM; Pereira AC; Onuchic LF; Jüppner H; Jorgetti V; Abensur H; Moysés RM
Am J Kidney Dis; 2018 Sep; 72(3):457-461. PubMed ID: 29548779
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome.
Ramnitz MS; Gourh P; Goldbach-Mansky R; Wodajo F; Ichikawa S; Econs MJ; White KE; Molinolo A; Chen MY; Heller T; Del Rivero J; Seo-Mayer P; Arabshahi B; Jackson MB; Hatab S; McCarthy E; Guthrie LC; Brillante BA; Gafni RI; Collins MT
J Bone Miner Res; 2016 Oct; 31(10):1845-1854. PubMed ID: 27164190
[TBL] [Abstract][Full Text] [Related]
6. Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action.
Folsom LJ; Imel EA
Curr Osteoporos Rep; 2015 Apr; 13(2):78-87. PubMed ID: 25656441
[TBL] [Abstract][Full Text] [Related]
7. Hyperphosphatemic familial tumoral calcinosis: odontostomatologic management and pathological features.
Favia G; Lacaita MG; Limongelli L; Tempesta A; Laforgia N; Cazzolla AP; Maiorano E
Am J Case Rep; 2014 Dec; 15():569-75. PubMed ID: 25537063
[TBL] [Abstract][Full Text] [Related]
8. Review of tumoral calcinosis: A rare clinico-pathological entity.
Fathi I; Sakr M
World J Clin Cases; 2014 Sep; 2(9):409-14. PubMed ID: 25232542
[TBL] [Abstract][Full Text] [Related]
9. Tumoral calcinosis: a case report.
Prasad J; Malua S; Sinha DK; Hassan F; Tekriwal R
Indian J Surg; 2007 Dec; 69(6):251-3. PubMed ID: 23132997
[TBL] [Abstract][Full Text] [Related]
10. FGF23 and syndromes of abnormal renal phosphate handling.
Bergwitz C; Jüppner H
Adv Exp Med Biol; 2012; 728():41-64. PubMed ID: 22396161
[TBL] [Abstract][Full Text] [Related]
11. Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).
Farrow EG; Imel EA; White KE
Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):735-47. PubMed ID: 22142751
[TBL] [Abstract][Full Text] [Related]
12. Disorders of phosphate homeostasis and tissue mineralisation.
Bergwitz C; Jüppner H
Endocr Dev; 2009; 16():133-56. PubMed ID: 19494665
[TBL] [Abstract][Full Text] [Related]
13. Hyperostosis with hyperphosphatemia and tumoral calcinosis: a case report.
Otukesh H; Hoseini R; Chalian H; Chalian M; Safarzadeh AE; Shakiba M; Poorian A
Pediatr Nephrol; 2007 Aug; 22(8):1235-7. PubMed ID: 17437133
[TBL] [Abstract][Full Text] [Related]
14. Tumoral calcinosis with hyperphosphatemia.
Mahadevan S; Adhisivam B; Kumar CN
Indian J Pediatr; 2005 Oct; 72(10):889-90. PubMed ID: 16272668
[TBL] [Abstract][Full Text] [Related]
15. Diffuse soft tissue calcification in tumoral calcinosis.
Feldman ES; Dalinka MK; Schumacher HR
Skeletal Radiol; 1981; 7(1):33-5. PubMed ID: 7336213
[No Abstract] [Full Text] [Related]
16. Tumoral calcinosis: case report and review.
Bishop AF; Destouet JM; Murphy WA; Gilula LA
Skeletal Radiol; 1982; 8(4):269-74. PubMed ID: 6755712
[TBL] [Abstract][Full Text] [Related]
17. Tumoral calcinosis revisited--common and uncommon features. Report of ten cases and review.
Metzker A; Eisenstein B; Oren J; Samuel R
Eur J Pediatr; 1988 Feb; 147(2):128-32. PubMed ID: 3366131
[TBL] [Abstract][Full Text] [Related]
18. Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide.
Lufkin EG; Wilson DM; Smith LH; Bill NJ; DeLuca HF; Dousa TP; Knox FG
J Clin Endocrinol Metab; 1980 Apr; 50(4):648-53. PubMed ID: 7364922
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide.
Yamaguchi T; Sugimoto T; Imai Y; Fukase M; Fujita T; Chihara K
Bone; 1995 Apr; 16(4 Suppl):247S-250S. PubMed ID: 7626311
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
